TCM product approved for sale in Singapore
Share - WeChat
Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.
Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.
On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.
- Typhoon Pulasan makes 2nd landfall in China
- Woman, 58, killed in Hunan dormitory complex
- Hefei e-commerce firm under probe for reportedly misleading consumers
- Man pleads guilty to child trafficking in Yunnan, following wife's death sentence
- Man jailed for smuggling 'ecological killer' turtles
- Mainland asks US to stop arming Taiwan